Developer of therapeutic discovery quantum molecular simulation engine designed to accelerate molecular discovery.
Developer of therapeutic discovery quantum molecular simulation engine designed to accelerate molecular discovery.
Drug Discovery📍 San Diego, CAFounded 2019
Current Valuation
$648M
as of 2026-Q2
PRIVATE
QL Price
$485.87M
-25% vs last round
QuantLogix's current estimate for Iambic, published 2026-09-27 — below the last disclosed round of $648M (2026-Q2).
Confidence
medium
Basis
secondary led
What backs this price
Last disclosed round
$648M
2026-Q2
weight 0.84
Secondary market print
$248.18M
2026-06-27
weight 0.58
How this price has held up
No round has priced for Iambic since QuantLogix began publishing a price for it, so there is nothing to grade yet. The claim above is on the record from 2026-09-27 and will be graded against the next priced round. See the full accuracy record →
Which publicly-traded funds already hold it, what $10,000 buys, and whether any route is open to you.
Cite this price as QuantLogix QL Price, Iambic, 2026-09-27 (b8015519490c9e53).
The id pins this exact claim, so a citation stays checkable after the price moves.
Model estimate for research — not a quote, target price, or investment advice.
IPO Outlookprivate
Is Iambic going public?
No. Iambic is private and has not filed to go public. There is no S-1 on file.
What is Iambic's valuation in 2026?
Iambic is valued at $648M as of 2026-Q2, set by its Series B ($27.77M, Apr 2026). That is the last confirmed mark, not a live price — private shares do not trade continuously.
Has Iambic filed an S-1?
No public S-1 is on file for Iambic.
How much has Iambic raised?
Iambic has raised $354.77M in total, most recently a Series B of $27.77M in Apr 2026.
Is Iambic publicly traded — can you buy Iambic stock?
No. Iambic is a private company — its shares are not listed on any exchange and there is no ticker. The routes to exposure are pre-IPO secondary marketplaces and funds (accredited investors), employee tender offers when the company runs one, and public companies with read-through exposure. QuantLogix maps every route it can verify for Iambic on its Pre-IPO Access Desk.
Answers are derived from the roster record shown on this page — filing status, last round and confirmed marks. Where the record is silent, the answer says so rather than guessing.
Exchange calendar terms from licensed market-data feeds. Expected dates marked est. are news-derived, not exchange-confirmed. Educational only, not a listing prediction.
Fundraising Status
Series B · $27.77M · 5 mo ago
privateTotal raised $354.77M
Secondary Market
Implied price / share
$1.25
Last round price / share
$3.26
vs last round
-61.7%
Open interest
3
Last round price vs secondary price
Secondary price return by period
Implied per-share price from private secondary transactions, as of Jun 2026. This is a point estimate, not a quote — the feed carries no bid, ask or spread, and a secondary print is evidence of what someone paid on that date rather than a live market. Compare across every tracked name →
Latest Funding Round
Round
Amount
Date
Lead Investor
Post-Money
Series B
$27.77M
Apr 2026
—
$648M
Vertical Intelligence — Biotech / Gene Therapy
Registered trials
1
1 active · 1 recruiting
Lead phase
Phase 1
most advanced registered study
Focus areas
HER2 Mutation-Related Tumors
HER2 · HER2-positive Breast Cancer
Latest trial start
2024-03-25
Name-verified against lead sponsor "Iambic Therapeutics, Inc" on ClinicalTrials.gov as of 2026-09-27. Verify on ClinicalTrials.gov ↗
Talent Signal
Hiring trend
▲ Hiring uptrend
+37% vs 2026-08
Open roles
26
via ashby
Product-build share
62%
engineering, research, product, design
Trajectory
expanding
product-led hiring — 62% of open roles build product; the rest are go-to-market and G&A.
No tracked executive churn; open roles trending up.
Open roles by month
Open roles by function
■ product-building ■ go-to-market / G&A
Associate Medical Director/Medical DirectorSr Associate Scientist I or II, Medicinal Chemistry Principal Scientist, Medicinal Chemistry Research Scientist II/Senior, Discovery Machine LearningPrincipal Medical WriterMachine Learning Scientist – Clinical Prediction
Counted from Iambic's live job board as of 2026-09-16; role functions classified from posting titles. Open-role counts are an activity signal, not headcount. Refreshed monthly.
Private-company numbers are not real-time. Reflects publicly disclosed valuations from press releases, news reports, and tender offers as of 2026-Q2. Refreshed quarterly.